Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

C1galt1-deficient mice exhibit thrombocytopenia due to abnormal terminal differentiation of megakaryocytes

Takashi Kudo, Takashi Sato, Kozue Hagiwara, Yukinori Kozuma, Takashi Yamaguchi, Yuzuru Ikehara, Michito Hamada, Ken Matsumoto, Masatsugu Ema, Soichiro Murata, Nobuhiro Ohkohchi, Hisashi Narimatsu, Satoru Takahashi

Blood (2013) 122 (9): 1649–1657.

https://doi.org/10.1182/blood-2012-12-471102

Published: 2013

Journal Articles

Genome-wide identification of endothelial cell–enriched genes in the mouse embryo

Haruka Takase, Ken Matsumoto, Rie Yamadera, Yoshiaki Kubota, Ayaka Otsu, Rumiko Suzuki, Hiroyuki Ishitobi, Hiromi Mochizuki, Takahiro Kojima, Shingo Takano, Kazuhiko Uchida, Satoru Takahashi, Masatsugu Ema

Blood (2012) 120 (4): 914–923.

https://doi.org/10.1182/blood-2011-12-398156

Published: 2012

Includes: Supplemental data

Journal Articles

Anti Tumor Effect of 2-Oxoglutarate through Inhibition of Angiogenesis in a Murine Tumor Model.

Ken Matsumoto, Naoshi Obara, Masaki Horie, Ayano Naka, Katsunori Utsugi, Shigehiko Imagawa

Blood (2008) 112 (11): 1599.

https://doi.org/10.1182/blood.V112.11.1599.1599

Published: 2008

Journal Articles

Detection of Hypoxia-Inducible Gene Manipulation.

Shigehiko Imagawa, MD, PhD, Masaki Horie, Ken Matsumoto, Ikuo Hirano, Norio Suzuki, PhD, Masayuki Yamamoto, MD

Blood (2007) 110 (11): 3662.

https://doi.org/10.1182/blood.V110.11.3662.3662

Published: 2007

Journal Articles

2-Oxoglutarate Down-Regulates Expression of Vascular Endothelial Growth Factor and Erythropoietin through Decreasing Hypoxia Inducible Factor-1 α and Inhibits Angiogenesis.

Shigehiko Imagawa, MD, PhD, Ken Matsumoto, PhD, Naoshi Obara, M.D, Norio Suzuki, PhD, Toshiro Nagasawa, MD, PhD, Masayuki Yamamoto, MD, PhD

Blood (2005) 106 (11): 3957.

https://doi.org/10.1182/blood.V106.11.3957.3957

Published: 2005

Journal Articles

Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease

Yoko Nakano, Shigehiko Imagawa, Ken Matsumoto, Christian Stockmann, Naoshi Obara, Norio Suzuki, Takeshi Doi, Tatsuhiko Kodama, Satoru Takahashi, Toshiro Nagasawa, Masayuki Yamamoto

Blood (2004) 104 (13): 4300–4307.

https://doi.org/10.1182/blood-2004-04-1631

Published: 2004

NARROW

C1galt1-deficient mice exhibit thrombocytopenia due to abnormal terminal differentiation of megakaryocytes

Genome-wide identification of endothelial cell–enriched genes in the mouse embryo

Anti Tumor Effect of 2-Oxoglutarate through Inhibition of Angiogenesis in a Murine Tumor Model.

Detection of Hypoxia-Inducible Gene Manipulation.

2-Oxoglutarate Down-Regulates Expression of Vascular Endothelial Growth Factor and Erythropoietin through Decreasing Hypoxia Inducible Factor-1 α and Inhibits Angiogenesis.

Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease

Email alerts

ASH Publications

American Society of Hematology

C1galt1-deficient mice exhibit thrombocytopenia due to abnormal terminal differentiation of megakaryocytes

Genome-wide identification of endothelial cell–enriched genes in the mouse embryo

Anti Tumor Effect of 2-Oxoglutarate through Inhibition of Angiogenesis in a Murine Tumor Model.

Detection of Hypoxia-Inducible Gene Manipulation.

2-Oxoglutarate Down-Regulates Expression of Vascular Endothelial Growth Factor and Erythropoietin through Decreasing Hypoxia Inducible Factor-1 α and Inhibits Angiogenesis.

Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only